Developing a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice and subsequently change antibiotic use.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 10 2020
Historique:
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 15 5 2021
Statut: epublish

Résumé

To develop a behavioural intervention package to support clinicians and patients to amend incorrect penicillin allergy records in general practice. The intervention aimed to: (1) support clinicians to refer patients for penicillin allergy testing (PAT), (2) support patients to attend for PAT and (3) support clinicians and patients to prescribe or consume penicillin, when indicated, following a negative PAT result. Theory-based, evidence-based and person-based approaches were used in the intervention development. We used evidence from a rapid review, two qualitative studies, and expert consultations with the clinical research team to identify the intervention 'guiding principles' and develop an intervention plan. Barriers and facilitators to the target behaviours were mapped to behaviour change theory in order to describe the proposed mechanisms of change. In the final stage, think-aloud interviews were conducted to optimise intervention materials. The collated evidence showed that the key barriers to referral of patients by clinicians were limited experience of referral and limited knowledge of referral criteria and PAT. Barriers for patients attending PAT were lack of knowledge of the benefits of testing and lack of motivation to get tested. The key barriers to the prescription and consumption of first-line penicillin following a negative test result were patient and clinician beliefs about the accuracy of PAT and whether taking penicillin was safe. Intervention materials were designed and developed to address these barriers. We present a novel behavioural intervention package designed to address the multiple barriers to uptake of PAT in general practice by clinicians and patients. The intervention development details how behaviour change techniques have been incorporated to hypothesise how the intervention is likely to work to help amend incorrect penicillin allergy records. The intervention will go on to be tested in a feasibility trial and randomised controlled trial in England.

Identifiants

pubmed: 33004384
pii: bmjopen-2019-035793
doi: 10.1136/bmjopen-2019-035793
pmc: PMC7534681
doi:

Substances chimiques

Anti-Bacterial Agents 0
Penicillins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e035793

Subventions

Organisme : Department of Health
ID : RP-PG-1214-20007
Pays : United Kingdom

Investigateurs

Jenny Boards (J)
Mandy East (M)
Philip Howard (P)
Bethany Shinkins (B)
Robert West (R)
Ly-Mee Yu (LM)

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: The authors have received funding from the National Institute for Health Research.

Références

Postgrad Med. 2017 Nov;129(8):915-920
pubmed: 28829234
Antibiotics (Basel). 2018 Aug 06;7(3):
pubmed: 30082596
Br J Anaesth. 2019 Jul;123(1):e110-e116
pubmed: 30915983
Open Forum Infect Dis. 2016 Sep 03;3(3):ofw153
pubmed: 27800527
PLoS One. 2018 May 3;13(5):e0196868
pubmed: 29723262
BMJ Open. 2020 Apr 8;10(4):e033516
pubmed: 32273313
BMC Fam Pract. 2012 Oct 11;13:101
pubmed: 23110756
Basic Clin Pharmacol Toxicol. 2006 Apr;98(4):357-62
pubmed: 16623858
J Antimicrob Chemother. 2019 Nov 1;74(11):3362-3370
pubmed: 31430366
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Eur J Hosp Pharm. 2021 Mar;28(2):71-75
pubmed: 33608433
J Antimicrob Chemother. 2019 Jul 1;74(7):2075-2082
pubmed: 31225607
Public Health. 2010 Feb;124(2):99-106
pubmed: 20167340
J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):252-7
pubmed: 24565481
Clin Exp Allergy. 2017 Nov;47(11):1362-1373
pubmed: 29028276
J Clin Pathol. 2011 Mar;64(3):192-9
pubmed: 21177267
BMC Med Res Methodol. 2014 May 10;14:62
pubmed: 24885751
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Int J Technol Assess Health Care. 2014 Jan;30(1):20-7
pubmed: 24451157
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
BMJ Open. 2018 May 18;8(5):e019865
pubmed: 29779008
Lancet. 2013 Oct 5;382(9899):1175-82
pubmed: 23915885
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
Implement Sci. 2017 Feb 23;12(1):25
pubmed: 28231840
J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1888-1893.e1
pubmed: 30877074
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547

Auteurs

Marta Santillo (M)

Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK marta.santillo@phc.ox.ac.uk.

Marta Wanat (M)

Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.

Mina Davoudianfar (M)

Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.

Emily Bongard (E)

Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.

Sinisa Savic (S)

Faculty of Medicine and Health, University of Leeds, Leeds, Leeds, UK.

Louise Savic (L)

Faculty of Medicine and Health, University of Leeds, Leeds, Leeds, UK.

Catherine Porter (C)

Healthcare Associated Infection Group, University of Leeds, Leeds, West Yorkshire, UK.

Joanne Fielding (J)

Healthcare Associated Infection Group, University of Leeds, Leeds, West Yorkshire, UK.

Christopher C Butler (CC)

Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.

Sue Pavitt (S)

University of Leeds, Leeds, UK.

Jonathan Sandoe (J)

Healthcare Associated Infection Group, University of Leeds, Leeds, West Yorkshire, UK.

Sarah Tonkin-Crine (S)

Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH